A phase 3 trial of Immunovant’s FcRn inhibitor batoclimab has hit its primary endpoint. But, having made a second-generation molecule its lead candidate last year, the biotech isn’t currently ...

Incyte took the candidate into phase 3 trials in the skin condition hidradenitis suppurativa (HS) after seeing (PDF) placebo-adjusted response rates of up to 27.7% in a mid-stage study.

A total of 209 patients received upadacitinib at a dose of 15 mg, 107 received upadacitinib at a dose of 7.5 mg, and 112 received placebo; 70% of the patients had new-onset giant-cell arteritis ...

CHICAGO (WGN) — As the third and final phase of Kennedy construction work ... IDOT originally projected the cost of the entire three year Kennedy Expressway construction project would be $ ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than ...

SCORPIO-PEP is the first and only Phase 3 study of a COVID-19 oral antiviral as a post-exposure prophylaxis to meet the primary endpoint of preventing COVID-19. * The study met both the primary ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

In October, AZ and Daiichi launched the phase 3 Tropion-Lung15 trial testing Datroway 6 mg/kg—either by itself or with Tagrisso—in post-Tagrisso EGFR-mutant NSCLC. The study bears an estimated ...

Phase 4 saw TV shows folded into the MCU's interconnected ... That will complete the second of the MCU's two Sagas to date, both of which contain three Phases. If this sounds like a lot, we ...

Stealth BioTherapeutics Inc. has reached 50 percent of the enrollment target in the global Phase 3 ReNEW study (NCT06373731) of elamipretide as a potential treatment in patients with dry age-related ...

A second Phase 3 trial, ReGAIN, is planned for 2025, with ReNEW study results anticipated in 2026. The ReNEW study for dry AMD is evaluating the efficacy, safety, and pharmacokinetics of daily ...